March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Chronic Intraocular Pressure Elevation on Ocular Blood Flow’s Response to Additional Pressure Challenge in Diabetes
Author Affiliations & Notes
  • Vickie H. Wong
    Optometry & Vision Sciences, University of Melbourne, Carlton, Australia
  • Bang V. Bui
    Optometry & Vision Sciences, University of Melbourne, Carlton, Australia
  • Zheng He
    Optometry & Vision Sciences, University of Melbourne, Carlton, Australia
  • Flora Hui
    Optometry & Vision Sciences, University of Melbourne, Carlton, Australia
  • Algis J. Vingrys
    Optometry & Vision Sciences, University of Melbourne, Carlton, Australia
  • Footnotes
    Commercial Relationships  Vickie H. Wong, None; Bang V. Bui, None; Zheng He, None; Flora Hui, None; Algis J. Vingrys, None
  • Footnotes
    Support  NHMRC 566570
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 266. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vickie H. Wong, Bang V. Bui, Zheng He, Flora Hui, Algis J. Vingrys; Chronic Intraocular Pressure Elevation on Ocular Blood Flow’s Response to Additional Pressure Challenge in Diabetes. Invest. Ophthalmol. Vis. Sci. 2012;53(14):266.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We consider whether diabetes renders retinal function susceptible to chronic intraocular pressure (IOP) elevation. We also consider whether diabetes and chronic IOP renders ocular blood flow (OBF) more sensitive to acute IOP stress.

Methods: : Baseline scotopic electroretinogram (-6.79 - 2.07 log cd.s.m-2) responses were measured in anaesthetised (60:5 mg/kg Ket:Xyl) dark-adapted (>12 hours) Long-Evans rats (age: 5 weeks) 2 weeks following citrate buffer (c, control) and streptozotocin injections (STZ, 65 mg/kg) to elevate blood glucose to >15 mmol/L. Two weeks later chronic IOP elevation was maintained over 4 weeks via fortnightly anterior chamber injections of 15µm microsphere suspended in 5% polyethylene glycol. IOP was measured in awake rats daily before and after chronic IOP induction (mean±SEM). Weekly functional assays were conducted thereafter (expressed relative to control baseline, %). Four weeks after IOP elevation, OBF (laser Doppler flowmetry) was measured in response to acute IOP challenge (10-100 mmHg, 3mins/5 mmHg). This was compared with IOP-OBF profile measured from STZ rats without chronic IOP elevation. Data are expressed relative to baseline (%, 10 mmHg).

Results: : Microsphere injections increased IOP from 24.0±0.3 to 30.7±1.3 and from 24.2±0.2 to 31.1±1.2 for control (n=7) and STZ (n=9) rats, respectively. Systolic blood pressures were similar (c: 108±5, STZ: 119±7 mmHg, P=0.17). Chronic IOP elevation affected diabetic retinal function more than controls for photoreceptor amplitude (c: -25.3±2.2, STZ: -17.2±3.0%; P=0.014), photoreceptor sensitivity (c: 0.5±1.8, STZ: -8.1±2.4%, P<0.05) and ON-bipolar cell sensitivity (c: 166.8±25.9, STZ: 64.8±18.7%, P<0.05). Ganglion cell function was 20.4±7.8% worse in diabetes than controls (P=0.025). Diabetes increased the susceptibility of OBF to acute IOP insult by ~10 mmHg (50% response, c [n=7]: 53.4, STZ [n=10]: 43.9 mmHg) when compared with controls. Chronic IOP overlay in STZ animals further increased OBF susceptibility to acute IOP challenge by a further ~8 mmHg (n=5, 50% response, ~30 mmHg). This effect was not seen from healthy animals.

Conclusions: : STZ-diabetes increases the susceptibility of retinal function to chronic IOP stress. Diabetes increases OBF response to acute IOP challenge, an effect exacerbated by chronic IOP overlay, suggesting impaired capacity to maintain normal retinal function under duress.

Keywords: diabetes • intraocular pressure • blood supply 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×